Shark Tooth Bio
PrivateLast Round
Pre Seed
Oct 1, 2025
Total Funding Raised
$650,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shark Tooth Bio is a biotechnology company dedicated to developing treatments for Charcot-Marie-Tooth Disease Type 1A (CMT1A) through strategic research partnerships and drug assembly.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shark Tooth Bio Comparables
Compare Shark Tooth Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MAAsiRNA | 80% | |
| Shift Pharmaceuticals | 79% | |
| Armatus Bio | 78% | |
Shark Tooth Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 1, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 61% MoM, from 707 to 1.1K.
- Apr 5, 2026
Monthly visitors increased 226% MoM.
Shark Tooth Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shark Tooth Bio's valuation, stock price, and market status.